investordatabase.org

UZH Life Sciences Fund

lsf.uzh.ch Direct investor

The UZH Life Sciences Fund provides early financing to UZH spin-offs in life sciences, biotech and medtech based on UZH research IP. It is a partnership between the University of Zurich and the Novartis Venture Fund, with investment decisions made by a joint committee.

UZH Life Sciences Fund is a public fund headquartered in Switzerland, founded in 2016. It invests directly in companies, in life sciences, biotech and medtech. 9 portfolio companies, as it reports.

“provides early financing for UZH spin-offs in life sciences, biotech and medtech with business ideas based on intellectual property resulting from research done at UZH”

— UZH Life Sciences Fund, own website
Layer
Direct investor
Type
Public fund
Stage
Not stated
Headquarters
Switzerland
Sectors
life sciences, biotech, medtech
Founded
2016
Portfolio
9 companies

Team, as UZH Life Sciences Fund publishes it

  • Beatrice Beck-Schimmer Board of Directors and Investment Committee (UZH)
  • Daniel Hug Board of Directors and Investment Committee (UZH)
  • Beat Steffen Board of Directors and Investment Committee (NVF - Chair)
  • Bart Dzikowski Board of Directors and Investment Committee (NVF)
  • Michio Painter Board Secretary, UZH
  • Mathias Frederiksen Board Observer, NVF
  • Elena Battistello Board Observer, NVF
  • Adrian Sigrist Unitectra
  • Dominik Heitzmann UZH Foundation

Names and roles exactly as listed on lsf.uzh.ch. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page UZH Life Sciences Fund publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 17664 · added 2026-10-26 · link last verified 2026-10-26 · confidence high

Similar investors

Listed under